Invention Grant
- Patent Title: Method of treating a CNS disorder using a water-soluble histone deacetylase inhibitor
-
Application No.: US15422090Application Date: 2017-02-01
-
Publication No.: US10278954B2Publication Date: 2019-05-07
- Inventor: Steven Streatfield Gill
- Applicant: RENISHAW PLC
- Applicant Address: GB Wotton-Under-Edge
- Assignee: RENISHAW PLC
- Current Assignee: RENISHAW PLC
- Current Assignee Address: GB Wotton-Under-Edge
- Agency: Oliff PLC
- Priority: GB1601773.3 20160201
- Main IPC: A61K31/40
- IPC: A61K31/40 ; A61K31/4045 ; A61K9/00 ; A61K9/107 ; A61K31/19 ; A61K31/555 ; A61K39/00 ; A61K45/06 ; A61K47/10
Abstract:
A method of treating a CNS disorder. The method comprises providing a water-soluble histone deacetylase inhibitor, and administering the water-soluble histone deactylase inhibitor directly into a brain via convection enhanced delivery.
Public/Granted literature
- US20170216256A1 METHOD OF TREATING A CNS DISORDER USING A WATER-SOLUBLE HISTONE DEACETYLASE INHIBITOR Public/Granted day:2017-08-03
Information query
